Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
idiopathic Multicentric Castleman's disease (iMCD) - Pipeline Insight, 2024
... growth prospects across the idiopathic Multicentric Castleman's disease (iMCD) market. A detailed picture of the idiopathic Multicentric Castleman's disease (iMCD) pipeline landscape is provided, which includes the disease overview and idiopathic Multicentric Castleman's disease (iMCD) ... Read More
-
Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2024
... insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist development. The report provides detailed coverage of the pipeline landscape for this ... Read More
-
Nocturnal Enuresis - Pipeline Insight, 2024
... picture of the Nocturnal Enuresis pipeline landscape is provided, which includes the disease overview and Nocturnal Enuresis treatment guidelines. The assessment part of the report embraces in-depth Nocturnal Enuresis commercial assessment and clinical assessment of ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024
... pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive ... Read More
-
Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024
... companies and 3+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Potassium channel antagonists - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034
... years, immunotherapy has undergone a new phase of development which is linked to the development of CAR-T cell therapy. It is anticipated that CAR-T cells will bring out the next big leap forward in leukemia ... Read More
-
2024 Global Clinical Trials Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
5-HT1 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
2024 Global Cell And Gene Therapy Clinical Trials Industry (2030 Outlook)
... (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market ... Read More
-
2024 Global Clinical Trial Supplies Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
CRO Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... USD 66,106.81 million in sales, which is a CAGR of 7.0% over the next few years. The COVID-19 pandemic had a big effect on the contract research organization (CRO) market because clinical trials were still ... Read More
-
Sigma Receptor Agonist - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2024
... 10.9% during the forecast period 2024-2030. North American market for Nicotinamide Mononucleotide (NMN) is estimated to increase from $ 59.88 million in 2023 to reach $ 120.04 million by 2030, at a CAGR of 9.73% ... Read More
-
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024
... and growth prospects across Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline ... Read More
-
GPCR-Targeting Therapies - Pipeline Insight, 2024
... picture of the GPCR-Targeting Therapies pipeline landscape is provided, which includes the disease overview and GPCR-Targeting Therapies treatment guidelines. The assessment part of the report embraces in-depth GPCR-Targeting Therapies commercial assessment and clinical assessment of ... Read More
-
Alpha-2 Agonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Anemia Associated with Chronic Kidney - Pipeline Insight, 2024
... growth prospects across the Anemia Associated with Chronic Kidney market. A detailed picture of the Anemia Associated with Chronic Kidney pipeline landscape is provided, which includes the disease overview and Anemia Associated with Chronic Kidney ... Read More
-
ANCA Vasculitis - Pipeline Insight, 2024
... picture of the ANCA Vasculitis pipeline landscape is provided, which includes the disease overview and ANCA Vasculitis treatment guidelines. The assessment part of the report embraces in-depth ANCA Vasculitis commercial assessment and clinical assessment of ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2024
... therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources ... Read More
-
Anti-Glomerular Basement Membrane (Anti-GBM) Disease - Pipeline Insight, 2024
... growth prospects across the Anti-Glomerular Basement Membrane (Anti-GBM) Disease market. A detailed picture of the Anti-Glomerular Basement Membrane (Anti-GBM) Disease pipeline landscape is provided, which includes the disease overview and Anti-Glomerular Basement Membrane (Anti-GBM) Disease ... Read More
-
Arginine Depletors - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Type 4 cyclic nucleotide phosphodiesterase inhibitors - Pipeline Insight, 2024
... Cyclic Nucleotide Phosphodiesterase Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2024
... Channel Blockers development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024
... prospects across Murine Double Minute 2 (MDM2) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental ... Read More
Research Assistance
